CERAMENT
Augmentation in Fragility Fractures
Key Facts
Indication
Augmentation in Fragility Fractures
Phase
Pre-Clinical/Exploratory
Status
Active
Company
About Bonesupport Holding AB
Bonesupport's mission is to revolutionize bone regeneration by overcoming the limitations of traditional bone grafts with its innovative CERAMENT® technology. The company has achieved significant milestones, including FDA approvals for CERAMENT G and V, and has transitioned into a revenue-generating commercial entity with a growing direct sales force. Its strategy focuses on expanding clinical indications, deepening market penetration in core geographies, and leveraging its platform for future product iterations to address a multi-billion dollar global market.
View full company profile